Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from PainReform ( (PRFX) ).
PainReform Ltd. announced that it has successfully raised approximately $3.17 million in gross proceeds from the exercise of warrants to purchase 494,650 ordinary shares. This financial influx, resulting from a warrant repricing transaction conducted in September 2024, strengthens the company’s fiscal position and supports its ongoing operational initiatives.
More about PainReform
PainReform Ltd. operates in the pharmaceutical industry, focusing primarily on the development and commercialization of reformulated pain therapeutics. The company is known for its efforts to enhance the effectiveness and safety of existing medications through innovative formulations.
Average Trading Volume: 3,238,290
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.94M
See more insights into PRFX stock on TipRanks’ Stock Analysis page.
